Romo1 is a negative-feedback regulator of Myc

Journal of Cell Science

Volumn 124, Issue 11, 2011, Pages 1911-1924

  Lee, Seung Baek ^a   Kim, Jung Jin ^a   Chung, Jin Sil ^a   Lee, Myeong Sok ^b   Lee, Kee Ho ^c   Kim, Byung Soo ^a   Tansey, William P ^d   Yoo, Young Do ^a  

^a Korea University College of Medicine   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

^d Simons Center for Quantitative Biology   (United States)

Author keywords

Myc; Romo1; ROS; Skp2

Indexed keywords

MYC PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; ROMO1 PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOPLASM; GROWTH STIMULATION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STEADY STATE; UBIQUITINATION; UPREGULATION;

CELL LINE; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; FEEDBACK, PHYSIOLOGICAL; G1 PHASE; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MYC; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 79958138508     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.079996     Document Type: Article

References (49)

1. Alvarez, E., Northwood, I. C., Gonzalez, F. A., Latour, D. A., Seth, A., Abate, C., Curran, T. and Davis, R. J. (1991). Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of Myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266, 15277-15285.
2. Arnold, H. K. and Sears, R. C. (2008). A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins. Cancer Metastasis Rev. 27, 147-158.
3. Bader, J. P., Hausman, F. A. and Ray, D. A. (1986). Intranuclear degradation of the transformation-inducing protein encoded by avian MC29 virus. J. Biol. Chem. 261, 8303-8308.
4. Bashir, T. and Pagano, M. (2003). Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv. Cancer Res. 88, 101-144.
5. Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M., Zupi, G. and Biroccio, A. (2006). c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell 21, 509-519.
6. Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R. and Magrath, I. (1993). Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5, 56-61.
7. Burdon, R. H. and Rice-Evans, C. (1989). Free radicals and the regulation of mammalian cell proliferation. Free Radic. Res. Commun. 6, 345-358.
8. Carrano, A. C., Eytan, E., Hershko, A. and Pagano, M. (1999). SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199.
9. Chung, J. S., Lee, S. B., Park, S. H., Kang, S. T., Na, A. R., Chang, T. S., Kim, H. J. and Yoo, Y. D. (2009). Mitochondrial reactive oxygen species originating from Romo1 exert an important role in normal cell cycle progression by regulating p27(Kip1) expression. Free Radic. Res. 43, 729-737.
10. Chung, Y. M., Kim, J. S. and Yoo, Y. D. (2006). A novel protein, Romo1, induces ROS production in the mitochondria. Biochem. Biophys. Res. Commun. 347, 649-655.
11. Chung, Y. M., Lee, S. B., Kim, H. J., Park, S. H., Kim, J. J., Chung, J. S. and Yoo, Y. D. (2008). Replicative senescence induced by Romo1-derived reactive oxygen species. J. Biol. Chem. 283, 33763-33771.
12. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
13. Finkel, T. (2003). Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.
14. Finkel, T. and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
15. Gao, D., Inuzuka, H., Tseng, A., Chin, R. Y., Toker, A. and Wei, W. (2009). Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat. Cell Biol. 11, 397-408.
16. Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N. and White, R. J. (2005). c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7, 311-318.
17. Gregory, M. A. and Hann, S. R. (2000). c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20, 2423-2435.
18. Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C. and Ciechanover, A. (1998). Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 95, 8058-8063.
19. Hann, S. R. (2006). Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin. Cancer Biol. 16, 288-302.
20. Hann, S. R. and Eisenman, R. N. (1984). Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4, 2486-2497.
21. Henriksson, M., Bakardjiev, A., Klein, G. and Luscher, B. (1993). Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8, 3199-3209.
22. Herbst, A., Salghetti, S. E., Kim, S. Y. and Tansey, W. P. (2004). Multiple cell-typespecific elements regulate Myc protein stability. Oncogene 23, 3863-3871.
23. Hiramatsu, Y., Kitagawa, K., Suzuki, T., Uchida, C., Hattori, T., Kikuchi, H., Oda, T., Hatakeyama, S., Nakayama, K. I., Yamamoto, T. et al. (2006). Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res. 66, 8477-8483.
24. Hwang, I. T., Chung, Y. M., Kim, J. J., Chung, J. S., Kim, B. S., Kim, H. J., Kim, J. S. and Yoo, Y. D. (2007). Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochem. Biophys. Res. Commun. 359, 304-310.
25. Iiyama, M., Kakihana, K., Kurosu, T. and Miura, O. (2006). Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell. Signal. 18, 174-182.
26. Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K. and Nakayama, K. I. (2003). Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. USA 100, 10231-10236.
27. Kim, J. J., Lee, S. B., Park, J. K. and Yoo, Y. D. (2010). TNF-[alpha]-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL. Cell Death Differ. 17, 1420-1434.
28. Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E. and Tansey, W. P. (2003). Skp2 regulates Myc protein stability and activity. Mol. Cell 11, 1177-1188.
29. Lee, S. B., Kim, J. J., Kim, T. W., Kim, B. S., Lee, M. S. and Yoo, Y. D. (2010). Serum deprivation-induced reactive oxygen species production is mediated by Romo1. Apoptosis 15, 204-218.
30. Lin, H. K., Wang, G., Chen, Z., Teruya-Feldstein, J., Liu, Y., Chan, C. H., Yang, W. L., Erdjument-Bromage, H., Nakayama, K. I., Nimer, S. et al. (2009). Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat. Cell Biol. 11, 420-432.
31. Lisztwan, J., Marti, A., Sutterluty, H., Gstaiger, M., Wirbelauer, C. and Krek, W. (1998). Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17, 368-383.
32. Miura, M., Hatakeyama, S., Hattori, K. and Nakayama, K. (1999). Structure and expression of the gene encoding mouse F-box protein, Fwd2. Genomics 62, 50-58.
33. Na, A. R., Chung, Y. M., Lee, S. B., Park, S. H., Lee, M. S. and Yoo, Y. D. (2008). A critical role for Romo1-derived ROS in cell proliferation. Biochem. Biophys. Res. Commun. 369, 672-678.
34. Nishitani, H., Sugimoto, N., Roukos, V., Nakanishi, Y., Saijo, M., Obuse, C., Tsurimoto, T., Nakayama, K. I., Nakayama, K., Fujita, M. et al. (2006). Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25, 1126-1136.
35. Park, T. J., Kim, J. Y., Park, S. H., Kim, H. S. and Lim, I. K. (2009). Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1. Exp. Cell Res. 315, 3152-3162.
36. Saksela, K., Makela, T. P., Hughes, K., Woodgett, J. R. and Alitalo, K. (1992). Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene 7, 347-353.
37. Salghetti, S. E., Kim, S. Y. and Tansey, W. P. (1999). Destruction of Myc by ubiquitinmediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726.
38. Sears, R., Leone, G., DeGregori, J. and Nevins, J. R. (1999). Ras enhances Myc protein stability. Mol. Cell 3, 169-179.
39. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K. and Nevins, J. R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514.
40. Seth, A., Alvarez, E., Gupta, S. and Davis, R. J. (1991). A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266, 23521-23524.
41. Tedesco, D., Lukas, J. and Reed, S. I. (2002). The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 16, 2946-2957.
42. Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344.
43. Tworkowski, K. A., Salghetti, S. E. and Tansey, W. P. (2002). Stable and unstable pools of Myc protein exist in human cells. Oncogene 21, 8515-8520.
44. Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M. and Wahl, G. M. (2002). c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044.
45. von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., Hydbring, P., Weidung, I., Nakayama, K., Nakayama, K. I. et al. (2003). The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11, 1189-1200.
46. Welcker, M., Orian, A., Jin, J., Grim, J. E., Harper, J. W., Eisenman, R. N. and Clurman, B. E. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 101, 9085-9090.
47. Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsunematsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K. and Nakayama, K. I. (2004). Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23, 2116-2125.
48. Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T. et al. (2004). A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6, 308-318.
49. Zhang, G. J., Safran, M., Wei, W., Sorensen, E., Lassota, P., Zhelev, N., Neuberg, D. S., Shapiro, G. and Kaelin, W. G., Jr (2004). Bioluminescent imaging of Cdk2 inhibition in vivo. Nat. Med. 10, 643-648.